CIPLACTIN (Cyproheptadine (4mg))
-15%

CIPLACTIN (Cyproheptadine (4mg))

Original price was: ₹61.20.Current price is: ₹52.20.

Placeholder

Original price was: ₹61.20.Current price is: ₹52.20.

Add to cart
Buy Now
Category: Tag:

Ciplactin Tablet is classified as an antihistamine and is prescribed for various allergic conditions. This medication effectively alleviates symptoms such as inflammation, itching, swelling, and skin rashes. Additionally, it serves as a stimulant for appetite, aiding those who may struggle with the desire to eat. Patients are advised to follow their healthcare provider’s instructions regarding dosage and duration, as the medication can be taken with or without food. Depending on individual needs, the medicine may be utilized sporadically when symptoms arise or regularly to prevent their occurrence. Prematurely discontinuing the medication might lead to the return of symptoms. Ciplactin is generally considered safe for use; however, caution is warranted as it may induce dizziness in some individuals. It is essential to discuss any pre-existing liver, kidney, or heart issues with your physician before starting this medication. Additionally, alcohol consumption is discouraged due to the potential for heightened drowsiness when combined with this product. Use this medicine only under medical supervision. Follow the dose and schedule exactly as advised. Do not stop abruptly without guidance. Keep a record of any unusual symptoms and share them with your clinician. Combine therapy with appropriate lifestyle measures and routine monitoring as recommended. Use this medicine only under medical supervision. Follow the dose and schedule exactly as advised. Do not stop abruptly without guidance. Keep a record of any unusual symptoms and share them with your clinician. Combine therapy with appropriate lifestyle measures and routine monitoring as recommended.

Reviews

There are no reviews yet.

Be the first to review “CIPLACTIN (Cyproheptadine (4mg))”

Your email address will not be published. Required fields are marked *

Top